VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

165 hedge funds and large institutions have $1.98B invested in Viridian Therapeutics in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+27
Holders Change %
+19.57%
% of All Funds
2.39%
Holding in Top 10
10
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+900%
% of All Funds
0.14%
New
44
Increased
66
Reduced
41
Closed
16
Calls
$13.9M
Puts
$12.9M
Net Calls
+$1.01M
Net Calls Change
+$3.94M

Top Buyers

1
DCM
1
Driehaus Capital Management
Illinois
$45.3M
2
EC
2
EcoR1 Capital
California
$44.6M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$254M
4
FFM
4
Fairmount Funds Management
Pennsylvania
$78.4M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$27.4M

Top Sellers

1
MC
1
Maverick Capital
Texas
$45.4M
2
GTC
2
Ghost Tree Capital
New York
$1.71M
3
PCH
3
Polar Capital Holdings
United Kingdom
$0
4
State Street
4
State Street
Massachusetts
$54.1M
5
RI
5
RTW Investments
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AGM
176
Alpine Global Management
New York
– -$179K -13,794 Closed
UOC
177
UBS O'Connor
Illinois
– -$131K -10,057 Closed
EC
178
EntryPoint Capital
New York
– -$72.5K -5,569 Closed
Pacer Advisors
179
Pacer Advisors
Pennsylvania
– -$10.7K -825 Closed
HT
180
Headlands Technologies
Illinois
– -$7.75K -596 Closed
4 5 6 7
8